Clinical Research Directory
Browse clinical research sites, groups, and studies.
Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP
Sponsor: University of Cologne
Summary
The objective of this national, prospective, multi-centre observational study is to describe the prescription rational and practice in Germany, confirm the efficacy of caplacizumab in a real-world setting, and identify predicting factors in iTTP-patients with regard to persistent autoimmune activity, therapy guidance and risk of complications. The rational is to develop new treatment algorithms that optimize overall patient outcome and reduce treatment cost.
Official title: Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (aTTP)- REACT-2020
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
350
Start Date
2021-03-25
Completion Date
2034-12-12
Last Updated
2024-12-09
Healthy Volunteers
No
Interventions
Cablivi®
Intervention with Cablivi® take place outside of the study
Locations (1)
University Hospital of Cologne
Cologne, Germany